BA
CELG

Bristlecone Advisors’s Celgene Corp CELG Stock Holding History

Bristlecone Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,855
Closed -$356K – 185
2019
Q2 		$356K Buy
+3,855
New +$366K 0.08% 142
2018
Q1 		– Sell
-2,404
Closed -$251K – 149
2017
Q4 		$251K Buy
2,404
+4
+0.2% +$451 0.08% 130
2017
Q3 		$350K Sell
2,400
-400
-14% -$54.5K 0.11% 113
2017
Q2 		$364K Hold
2,800
– – 0.12% 116
2017
Q1 		$348K Hold
2,800
– – 0.12% 115
2016
Q4 		$324K Sell
2,800
-270
-9% -$30.1K 0.12% 120
2016
Q3 		$321K Buy
+3,070
New +$332K 0.12% 125
2016
Q2 		– Sell
-3,355
Closed -$336K – 163
2016
Q1 		$336K Sell
3,355
-696
-17% -$71.7K 0.13% 127
2015
Q4 		$485K Buy
+4,051
New +$469K 0.2% 110

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bristlecone Advisors's CELG Position: Q3 2019 in Review

Bristlecone Advisors sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 3,855 shares — an estimated $356K sold.

Bristlecone Advisors first reported a position in CELG in Q4 2015 and held it in 9 quarters. The position peaked at $485K in Q4 2015. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Bristlecone Advisors reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Bristlecone Advisors sold 3,855 Celgene Corp shares in Q3 2019, an estimated $356K.
  • Bristlecone Advisors first reported a position in Celgene Corp in Q4 2015 and held it in 9 quarters.
  • Bristlecone Advisors's Celgene Corp position peaked at $485K in Q4 2015.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Bristlecone Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.